Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Thalassemia × Mesna × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 3 Hematologic Neoplasms 3 Sarcoma 2 Osteosarcoma 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Kidney Neoplasms 2 Hodgkin Disease 2 Carcinoma, Renal Cell 2 Wilms Tumor 1 Thalassemia 1 Stomach Neoplasms 1 Rhabdoid Tumor 1 Retinoblastoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Optic Nerve Glioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1

Interventions

fludarabine phosphate 2 Cyclophosphamide 2 fludarabine 1 Whole-Body Irradiation 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Busulfan 1 Alemtuzumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡